Recent Company News

• 06:16 AM ET Feb 20, 2026
  

  EU Commission invests €225M to deliver next-generation influenza vaccines

• 02:06 AM ET Feb 18, 2026
  

  Bavarian Nordic receives $22.5M contract for its Mpox and Smallpox vaccine from the Government of Canada (DKK 193.75, 0.00)

• 03:28 AM ET Feb 09, 2026
  

  Bavarian Nordic completes the first tranche of share buy-back program (DKK 194.35, +0.95)

• 02:54 AM ET Feb 03, 2026
  

  Bavarian Nordic A/S reinstated buy at Jefferies; prior rating was buy (DKK 191.55, 0.00)

• 02:52 AM ET Dec 02, 2025
  

  StreetAccount Summary - European pre-market trading update

• 02:10 AM ET Jan 07, 2026
  

  Bavarian Nordic A/S launches DKK 150M first tranche of DKK 500M share buy-back program announced on 2-Dec-25 (DKK 197.50, 0.00)

• 04:05 AM ET Dec 02, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:03 AM ET Dec 02, 2025
  

  Bavarian Nordic to launch share buy-back program of up to DKK 500M (DKK 187.40, 0.00)

• 01:01 AM ET Dec 02, 2025
  

  Bavarian Nordic A/S re-initiated buy at Danske Bank; prior rating was buy